JP2007244388A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007244388A5 JP2007244388A5 JP2007106593A JP2007106593A JP2007244388A5 JP 2007244388 A5 JP2007244388 A5 JP 2007244388A5 JP 2007106593 A JP2007106593 A JP 2007106593A JP 2007106593 A JP2007106593 A JP 2007106593A JP 2007244388 A5 JP2007244388 A5 JP 2007244388A5
- Authority
- JP
- Japan
- Prior art keywords
- vegf2
- polypeptide
- cells
- sequence
- dna
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/465,968 US6608182B1 (en) | 1994-03-08 | 1995-06-06 | Human vascular endothelial growth factor 2 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP9501427A Division JPH11513883A (ja) | 1995-06-06 | 1996-06-06 | ヒト血管内皮増殖因子２ |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2007244388A JP2007244388A (ja) | 2007-09-27 |
| JP2007244388A5 true JP2007244388A5 (enExample) | 2008-04-03 |
Family
ID=23849909
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP9501427A Withdrawn JPH11513883A (ja) | 1995-06-06 | 1996-06-06 | ヒト血管内皮増殖因子２ |
| JP11147333A Withdrawn JP2000069982A (ja) | 1995-06-06 | 1999-05-26 | ヒト血管内皮増殖因子２ |
| JP2007106593A Pending JP2007244388A (ja) | 1995-06-06 | 2007-04-13 | ヒト血管内皮増殖因子２ |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP9501427A Withdrawn JPH11513883A (ja) | 1995-06-06 | 1996-06-06 | ヒト血管内皮増殖因子２ |
| JP11147333A Withdrawn JP2000069982A (ja) | 1995-06-06 | 1999-05-26 | ヒト血管内皮増殖因子２ |
Country Status (10)
| Country | Link |
|---|---|
| US (3) | US6608182B1 (enExample) |
| EP (1) | EP0837934B1 (enExample) |
| JP (3) | JPH11513883A (enExample) |
| KR (1) | KR100511692B1 (enExample) |
| CN (2) | CN1186518A (enExample) |
| AT (1) | ATE347595T1 (enExample) |
| AU (1) | AU714484B2 (enExample) |
| CA (1) | CA2224093C (enExample) |
| DE (1) | DE69636752T2 (enExample) |
| WO (1) | WO1996039515A1 (enExample) |
Families Citing this family (73)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6824777B1 (en) | 1992-10-09 | 2004-11-30 | Licentia Ltd. | Flt4 (VEGFR-3) as a target for tumor imaging and anti-tumor therapy |
| US7109308B1 (en) | 1994-03-08 | 2006-09-19 | Human Genome Sciences, Inc. | Antibodies to human vascular endothelial growth factor 2 |
| US6734285B2 (en) | 1994-03-08 | 2004-05-11 | Human Genome Sciences, Inc. | Vascular endothelial growth factor 2 proteins and compositions |
| US7186688B1 (en) | 1994-03-08 | 2007-03-06 | Human Genome Sciences, Inc. | Methods of stimulating angiogenesis in a patient by administering vascular endothelial growth factor 2 |
| US5932540A (en) | 1994-03-08 | 1999-08-03 | Human Genome Sciences, Inc. | Vascular endothelial growth factor 2 |
| DK0751992T3 (da) | 1994-03-08 | 2006-03-06 | Human Genome Sciences Inc | Karendotelvækstfaktor 2 |
| US6040157A (en) * | 1994-03-08 | 2000-03-21 | Human Genome Sciences, Inc. | Vascular endothelial growth factor 2 |
| US6608182B1 (en) * | 1994-03-08 | 2003-08-19 | Human Genome Sciences, Inc. | Human vascular endothelial growth factor 2 |
| US7153827B1 (en) | 1994-03-08 | 2006-12-26 | Human Genome Sciences, Inc. | Vascular endothelial growth factor 2 and methods of use |
| US7597886B2 (en) | 1994-11-07 | 2009-10-06 | Human Genome Sciences, Inc. | Tumor necrosis factor-gamma |
| US6245530B1 (en) | 1995-08-01 | 2001-06-12 | Ludwig Institute For Cancer Research | Receptor ligand |
| US6818220B1 (en) | 1994-11-14 | 2004-11-16 | Licentia Ltd. | Vascular endothelial growth factor C (VEGF-C) protein and gene mutants thereof, and uses thereof |
| WO1998033917A1 (en) * | 1994-11-14 | 1998-08-06 | The Ludwig Institute For Cancer Research | Vascular endothelial growth factor c (vegf-c) protein and gene, mutants thereof, and uses thereof |
| US6403088B1 (en) | 1995-08-01 | 2002-06-11 | Helsinki University Licensing, Ltd. | Antibodies reactive with VEGF-C, a ligand for the Flt4 receptor tyrosine kinase (VEGFR-3) |
| US6645933B1 (en) | 1995-08-01 | 2003-11-11 | Helsinki University Licensing Ltd. Oy | Receptor ligand VEGF-C |
| US6221839B1 (en) | 1994-11-14 | 2001-04-24 | Helsinki University Licensing Ltd. Oy | FIt4 ligand and methods of use |
| US6130071A (en) * | 1997-02-05 | 2000-10-10 | Helsinki University Licensing, Ltd. | Vascular endothelial growth factor C (VEGF-C) ΔCys156 protein and gene, and uses thereof |
| US7429646B1 (en) | 1995-06-05 | 2008-09-30 | Human Genome Sciences, Inc. | Antibodies to human tumor necrosis factor receptor-like 2 |
| US7727761B2 (en) | 1995-08-01 | 2010-06-01 | Vegenics Limited | Vascular endothelial growth factor C (VEGF-C) protein and gene, mutants thereof, and uses thereof |
| AU755708B2 (en) * | 1995-08-01 | 2002-12-19 | Vegenics Limited | Receptor ligand VEGF-C |
| US6361946B1 (en) | 1997-02-05 | 2002-03-26 | Licentia Ltd | Vascular endothelial growth factor C (VEGF-C) protein and gene, mutants thereof, and uses thereof |
| AU2003201371B2 (en) * | 1995-08-01 | 2007-03-01 | Helsinki University Licensing Ltd. Oy | Receptor Ligand VEGF-C |
| PT848755E (pt) * | 1995-09-08 | 2003-12-31 | Genentech Inc | Proteina relacionada com o vegf |
| WO1997017442A1 (en) | 1995-11-08 | 1997-05-15 | Immunex Corporation | Flk-1 binding protein |
| US6994989B1 (en) | 1995-11-08 | 2006-02-07 | Immunex Corp. | FLK-1 binding proteins |
| US6713061B1 (en) | 1996-03-12 | 2004-03-30 | Human Genome Sciences, Inc. | Death domain containing receptors |
| WO1997033904A1 (en) | 1996-03-12 | 1997-09-18 | Human Genome Sciences, Inc. | Death domain containing receptors |
| US7357927B2 (en) | 1996-03-12 | 2008-04-15 | Human Genome Sciences, Inc. | Death domain containing receptors |
| US7964190B2 (en) | 1996-03-22 | 2011-06-21 | Human Genome Sciences, Inc. | Methods and compositions for decreasing T-cell activity |
| US6635743B1 (en) | 1996-03-22 | 2003-10-21 | Human Genome Sciences, Inc. | Apoptosis inducing molecule II and methods of use |
| US20060171907A1 (en) * | 1996-11-21 | 2006-08-03 | The Procter & Gamble Company | Oral care compositions providing enhanced whitening and stain prevention |
| US7125714B2 (en) | 1997-02-05 | 2006-10-24 | Licentia Ltd. | Progenitor cell materials and methods |
| DE69830320T2 (de) * | 1997-03-07 | 2006-02-02 | The Wistar Institute Of Anatomy And Biology | Verwendung von Adenoviralen Vektoren, die PDGF oder VEGF exprimieren, ZUR HEILUNG VON GEWEBSDEFEKTEN UND ZUR INDUZIERUNG DER HYPERVASKULITÄT IN SÄUGERGEWEBEN |
| US6676937B1 (en) | 1998-03-09 | 2004-01-13 | Caritas St. Elizabeth's Medical Center Of Boston Inc. | Compositions and methods for modulating vascularization |
| JP2002505873A (ja) * | 1998-03-13 | 2002-02-26 | ヒューマン ジノーム サイエンシーズ， インコーポレイテッド | 血管内皮増殖因子２ |
| JP4841724B2 (ja) | 1998-10-09 | 2011-12-21 | ベジェニクス ピーティーワイ リミテッド | 腫瘍イメージングおよび抗腫瘍治療の標的としてのＦｌｔ４（ＶＥＲＧ−３） |
| US6958147B1 (en) | 1998-10-26 | 2005-10-25 | Licentia Ltd | Use of VEGF-C to prevent restenosis |
| US6783953B1 (en) | 1998-12-22 | 2004-08-31 | Janssen Pharmaceutica N.V. | Vascular endothelial growth factor-X |
| US7223724B1 (en) | 1999-02-08 | 2007-05-29 | Human Genome Sciences, Inc. | Use of vascular endothelial growth factor to treat photoreceptor cells |
| WO2000050620A2 (en) | 1999-02-26 | 2000-08-31 | Human Genome Sciences, Inc. | Human endokine alpha and methods of use |
| US6764820B2 (en) * | 1999-03-26 | 2004-07-20 | Ludwig Institute For Cancer Research | Screening for lymphatic disorders involving the FLT4 receptor tyrosine kinase (VEGFR-3) |
| WO2000058511A1 (en) * | 1999-03-26 | 2000-10-05 | Ludwig Institute For Cancer Research | Screening and therapy for lymphatic disorders involving the flt4 receptor tyrosine kinase (vegfr-3) |
| AU3988401A (en) * | 2000-02-25 | 2001-09-03 | Ludwig Inst Cancer Res | Materials and methods involving hybrid vascular endothelial growth factor dnas and proteins |
| US7291597B2 (en) * | 2000-04-06 | 2007-11-06 | Franco Wayne P | Growth factor therapy mobilization of stem cells into the peripheral blood |
| US7288521B2 (en) * | 2000-04-06 | 2007-10-30 | Franco Wayne P | Growth factor therapy mobilization of stem cells into the peripheral blood |
| US6926898B2 (en) | 2000-04-12 | 2005-08-09 | Human Genome Sciences, Inc. | Albumin fusion proteins |
| KR20020059609A (ko) * | 2000-08-04 | 2002-07-13 | 벤슨 로버트 에이치. | 혈관 내피 성장 인자 ２ |
| US7067317B2 (en) | 2000-12-07 | 2006-06-27 | Sangamo Biosciences, Inc. | Regulation of angiogenesis with zinc finger proteins |
| WO2002046412A2 (en) | 2000-12-07 | 2002-06-13 | Sangamo Biosciences, Inc. | Regulation of angiogenesis with zinc finger proteins |
| US7611711B2 (en) * | 2001-01-17 | 2009-11-03 | Vegenics Limited | VEGFR-3 inhibitor materials and methods |
| JP4669984B2 (ja) * | 2001-01-19 | 2011-04-13 | ベジェニクス リミテッド | 腫瘍画像化のターゲットとしてのＦ１ｔ４（ＶＥＧＦＲ−３）および抗腫瘍療法 |
| US20050232921A1 (en) * | 2001-04-13 | 2005-10-20 | Rosen Craig A | Vascular endothelial growth factor 2 |
| US20030176674A1 (en) * | 2001-04-13 | 2003-09-18 | Rosen Craig A. | Vascular endothelial growth factor 2 |
| JP2004536579A (ja) * | 2001-04-13 | 2004-12-09 | ヒューマン ジノーム サイエンシーズ， インコーポレイテッド | 血管内皮増殖因子２ |
| US7402312B2 (en) | 2001-04-13 | 2008-07-22 | Human Genome Sciences, Inc. | Antibodies to vascular endothelial growth factor 2 (VEGF-2) |
| AU2002322461B2 (en) * | 2001-07-12 | 2007-12-06 | Vegenics Limited | Lymphatic endothelial cells materials and methods |
| AU2002331669A1 (en) | 2001-08-23 | 2003-03-10 | The Wistar Institute Of Anatomy And Biology | An organotypic intestinal culture and methods of use thereof |
| US20040214766A1 (en) * | 2001-10-01 | 2004-10-28 | Kari Alitalo | VEGF-C or VEGF-D materials and methods for treatment of neuropathologies |
| US20030113324A1 (en) * | 2001-10-01 | 2003-06-19 | Kari Alitalo | Neuropilin/VEGF-C/VEGFR-3 materials and methods |
| CA2841097A1 (en) | 2001-12-21 | 2003-07-24 | Human Genome Sciences, Inc. | Albumin and g-csf fusion proteins |
| AU2003274463B2 (en) | 2002-06-10 | 2009-10-29 | University Of Rochester | Gene differentially expressed in breast and bladder cancer and encoded polypeptides |
| US20040120950A1 (en) * | 2002-12-20 | 2004-06-24 | Kari Alitalo | Modulation of VEGF-C/VEGFR-3 interactions in the treatment of rheumatoid arthritis |
| AU2004209668A1 (en) * | 2003-02-04 | 2004-08-19 | Flanders Interuniversity Institute For Biotechnology | VEGF-B and PDGF modulation of stem cells |
| US20050032697A1 (en) * | 2003-06-12 | 2005-02-10 | Kari Alitalo | Heparin binding VEGFR-3 ligands |
| WO2005011722A2 (en) * | 2003-06-12 | 2005-02-10 | Ludwig Institute For Cancer Research | Use of vegf-c or vegf-d in reconstructive surgery |
| US7597884B2 (en) | 2004-08-09 | 2009-10-06 | Alios Biopharma, Inc. | Hyperglycosylated polypeptide variants and methods of use |
| CA2599004C (en) | 2005-02-28 | 2015-05-26 | Sangamo Biosciences, Inc. | Anti-angiogenic methods and compositions |
| CN101878757A (zh) * | 2005-06-21 | 2010-11-10 | 渗透治疗有限公司 | 用于增强血管通路的方法和组合物 |
| NZ586544A (en) | 2007-12-26 | 2012-07-27 | Vaccinex Inc | Anti-c35 antibody in combination with an ani-her2 antibody in cancer therapies and methods |
| EP2310507A4 (en) | 2008-07-08 | 2013-03-20 | David Gladstone Inst | METHOD AND COMPOSITIONS FOR ANGIOGENIC MODULATION |
| MY170528A (en) | 2013-02-18 | 2019-08-09 | Vegenics Pty Ltd | Vegfr-3 ligand binding molecules and uses thereof |
| CN108339154A (zh) * | 2017-01-25 | 2018-07-31 | 中国科学院遗传与发育生物学研究所 | 一种诱导颅脑损伤组织再生的功能生物材料及其应用 |
| CN111303271B (zh) * | 2020-02-19 | 2022-02-01 | 西安交通大学医学院第一附属医院 | 一种用于治疗肺纤维化的血小板源性生长因子重组疫苗及其应用 |
Family Cites Families (66)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3587801T2 (de) | 1984-12-24 | 1994-10-20 | Merck & Co Inc | Zubereitung enthaltend ein saures Fibroblastewachstumfaktor (aFGF). |
| US5073492A (en) * | 1987-01-09 | 1991-12-17 | The Johns Hopkins University | Synergistic composition for endothelial cell growth |
| JPS6438100A (en) | 1987-07-31 | 1989-02-08 | Toray Industries | Vascular endothelial cell growth factor |
| JPH02117698A (ja) | 1988-10-27 | 1990-05-02 | Toray Ind Inc | 血管内皮細胞成長因子 |
| US5240848A (en) | 1988-11-21 | 1993-08-31 | Monsanto Company | Dna sequences encoding human vascular permeability factor having 189 amino acids |
| US5693622A (en) | 1989-03-21 | 1997-12-02 | Vical Incorporated | Expression of exogenous polynucleotide sequences cardiac muscle of a mammal |
| CA2017379C (en) | 1989-05-24 | 2002-06-25 | Kenneth A. Thomas, Jr. | Purification and characterization of a glioma-derived growth factor |
| US5194596A (en) * | 1989-07-27 | 1993-03-16 | California Biotechnology Inc. | Production of vascular endothelial cell growth factor |
| US5219739A (en) | 1989-07-27 | 1993-06-15 | Scios Nova Inc. | DNA sequences encoding bVEGF120 and hVEGF121 and methods for the production of bovine and human vascular endothelial cell growth factors, bVEGF120 and hVEGF121 |
| DE69132040T2 (de) | 1990-09-21 | 2000-11-02 | Merck & Co., Inc. | Wachstumsfaktor II für vaskuläre Endothelzellen |
| ATE221915T1 (de) | 1991-02-22 | 2002-08-15 | American Cyanamid Co | Identifizierung eines menschlichen rezeptor- tyrosinkinasegens |
| DE69229454T2 (de) | 1991-03-28 | 2000-01-05 | Merck & Co., Inc. | Untereinheit-C des vaskulären endothelialen Zellwachstumsfaktors |
| US5185438A (en) | 1991-04-02 | 1993-02-09 | The Trustees Of Princeton University | Nucleic acids encoding hencatoporetic stem cell receptor flk-2 |
| US5234908A (en) | 1991-04-12 | 1993-08-10 | Creative Biomolecules, Inc. | Method of treating gastrointestinal ulcers with platelet derived growth factor |
| US5661133B1 (en) | 1991-11-12 | 1999-06-01 | Univ Michigan | Collateral blood vessel formation in cardiac muscle by injecting a dna sequence encoding an angiogenic protein |
| US5861301A (en) | 1992-02-20 | 1999-01-19 | American Cayanamid Company | Recombinant kinase insert domain containing receptor and gene encoding same |
| US5326695A (en) * | 1992-05-15 | 1994-07-05 | Ludwig Institute For Cancer Research | Platelet derived growth factor agonists |
| US5776755A (en) * | 1992-10-09 | 1998-07-07 | Helsinki University Licensing, Ltd. | FLT4, a receptor tyrosine kinase |
| DE69331526T2 (de) | 1992-11-18 | 2002-10-24 | Arch Development Corp., Chicago | Adenovirus gelenkter gen-transfer zum herz- und glatten vaskularen muskel |
| US5922572A (en) | 1994-01-25 | 1999-07-13 | Human Genome Sciences, Inc. | Polynucleotides encoding haemopoietic maturation factor |
| US5817485A (en) | 1994-03-08 | 1998-10-06 | Human Genome Sciences, Inc. | Nucleic acids and cells for recombinant production of fibroblast growth factor-10 |
| US6608182B1 (en) * | 1994-03-08 | 2003-08-19 | Human Genome Sciences, Inc. | Human vascular endothelial growth factor 2 |
| US5633147A (en) | 1994-03-08 | 1997-05-27 | Human Genome Sciences, Inc. | Transforming growth factor αH1 |
| DK0751992T3 (da) | 1994-03-08 | 2006-03-06 | Human Genome Sciences Inc | Karendotelvækstfaktor 2 |
| US6040157A (en) | 1994-03-08 | 2000-03-21 | Human Genome Sciences, Inc. | Vascular endothelial growth factor 2 |
| US5932540A (en) | 1994-03-08 | 1999-08-03 | Human Genome Sciences, Inc. | Vascular endothelial growth factor 2 |
| JPH10508742A (ja) | 1994-08-23 | 1998-09-02 | ヒューマン・ジェノム・サイエンシズ・インコーポレイテッド | ヒトケモカインポリペプチド |
| US5652225A (en) | 1994-10-04 | 1997-07-29 | St. Elizabeth's Medical Center Of Boston, Inc. | Methods and products for nucleic acid delivery |
| US6645933B1 (en) | 1995-08-01 | 2003-11-11 | Helsinki University Licensing Ltd. Oy | Receptor ligand VEGF-C |
| US6403088B1 (en) * | 1995-08-01 | 2002-06-11 | Helsinki University Licensing, Ltd. | Antibodies reactive with VEGF-C, a ligand for the Flt4 receptor tyrosine kinase (VEGFR-3) |
| WO1998033917A1 (en) | 1994-11-14 | 1998-08-06 | The Ludwig Institute For Cancer Research | Vascular endothelial growth factor c (vegf-c) protein and gene, mutants thereof, and uses thereof |
| US6130071A (en) * | 1997-02-05 | 2000-10-10 | Helsinki University Licensing, Ltd. | Vascular endothelial growth factor C (VEGF-C) ΔCys156 protein and gene, and uses thereof |
| US6221839B1 (en) * | 1994-11-14 | 2001-04-24 | Helsinki University Licensing Ltd. Oy | FIt4 ligand and methods of use |
| US6245530B1 (en) * | 1995-08-01 | 2001-06-12 | Ludwig Institute For Cancer Research | Receptor ligand |
| US5792453A (en) | 1995-02-28 | 1998-08-11 | The Regents Of The University Of California | Gene transfer-mediated angiogenesis therapy |
| US5928939A (en) | 1995-03-01 | 1999-07-27 | Ludwig Institute For Cancer Research | Vascular endothelial growth factor-b and dna coding therefor |
| US5607918A (en) | 1995-03-01 | 1997-03-04 | Ludwig Institute For Cancer Research | Vascular endothelial growth factor-B and DNA coding therefor |
| WO1997000271A1 (en) | 1995-06-14 | 1997-01-03 | The Regents Of The University Of California | Novel high affinity human antibodies to tumor antigens |
| US6361946B1 (en) | 1997-02-05 | 2002-03-26 | Licentia Ltd | Vascular endothelial growth factor C (VEGF-C) protein and gene, mutants thereof, and uses thereof |
| EP0859841B1 (en) | 1995-08-18 | 2002-06-19 | MorphoSys AG | Protein/(poly)peptide libraries |
| PT848755E (pt) | 1995-09-08 | 2003-12-31 | Genentech Inc | Proteina relacionada com o vegf |
| US6121246A (en) | 1995-10-20 | 2000-09-19 | St. Elizabeth's Medical Center Of Boston, Inc. | Method for treating ischemic tissue |
| WO1997017442A1 (en) | 1995-11-08 | 1997-05-15 | Immunex Corporation | Flk-1 binding protein |
| US5641750A (en) | 1995-11-29 | 1997-06-24 | Amgen Inc. | Methods for treating photoreceptors using glial cell line-derived neurotrophic factor (GDNF) protein product |
| CA2263143A1 (en) | 1996-08-13 | 1998-02-19 | Human Genome Sciences, Inc. | Keratinocyte growth factor-2 (kgf-2 or fibroblast growth factor-12, fgf-12) |
| EP0956339B1 (en) | 1996-08-23 | 2005-10-12 | Ludwig Institute For Cancer Research | Recombinant vascular endothelial cell growth factor d (vegf-d) |
| AU5439998A (en) | 1996-12-06 | 1998-06-29 | Zymogenetics Inc. | Vascular endothelial growth factor |
| DE69830320T2 (de) | 1997-03-07 | 2006-02-02 | The Wistar Institute Of Anatomy And Biology | Verwendung von Adenoviralen Vektoren, die PDGF oder VEGF exprimieren, ZUR HEILUNG VON GEWEBSDEFEKTEN UND ZUR INDUZIERUNG DER HYPERVASKULITÄT IN SÄUGERGEWEBEN |
| NZ500530A (en) | 1997-04-25 | 2001-12-21 | Collateral Therapeutics | Truncated VEGF-B, VEGF-C, VEGF-3, PlGF, VRF-2, poxvirus ORF-1 and ORF-2 proteins |
| US6790938B1 (en) | 1997-06-06 | 2004-09-14 | Asat Ag Applied Science & Technology | Anti-GPIIb/IIIa recombinant antibodies |
| AU8536998A (en) | 1997-06-10 | 1998-12-30 | Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. | Regulatory sequences involved in hypoxia regulated gene expression and uses thereof |
| WO1999002545A2 (en) | 1997-07-08 | 1999-01-21 | Novopharm Biotech Inc. | Antigen binding fragments, designated 4b5, that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for the prophylaxis and detection of cancers |
| JP2001514867A (ja) | 1997-08-15 | 2001-09-18 | ルードヴィッヒ・インスティテュート・フォア・キャンサー・リサーチ | 内皮のタンパク分解活性および／または血管形成活性の刺激、調節および／または阻害 |
| GB9722131D0 (en) | 1997-10-20 | 1997-12-17 | Medical Res Council | Method |
| WO1999021590A1 (en) | 1997-10-27 | 1999-05-06 | Merck & Co., Inc. | Gene therapy for stimulation of angiogenesis |
| JP2002505873A (ja) | 1998-03-13 | 2002-02-26 | ヒューマン ジノーム サイエンシーズ， インコーポレイテッド | 血管内皮増殖因子２ |
| CA2361615A1 (en) | 1999-02-08 | 2000-08-10 | Human Genome Sciences, Inc. | The use of vascular endothelial growth factor 2 antagonist in the treatment of an injury to or disorder of an eye |
| DE10027695A1 (de) | 1999-05-27 | 2001-04-19 | Max Delbrueck Centrum | Vakzine gegen konformationsabhängige Antigene sowie gegen Antigene, die keine oder nicht ausschließlich Proteine oder Peptide sind |
| AU5306700A (en) | 1999-06-03 | 2000-12-28 | Human Genome Sciences, Inc. | Angiogenic proteins and uses thereof |
| AU2001233277B2 (en) | 2000-02-03 | 2004-06-03 | Millennium Pharmaceuticals, Inc. | Humanized anti-ccr2 antibodies and methods of use therefor |
| SK12942002A3 (sk) | 2000-02-10 | 2003-05-02 | Abbott Laboratories | Protilátky viažuce ľudský interleukín-18, spôsoby ich výroby a použitia |
| KR20020059609A (ko) | 2000-08-04 | 2002-07-13 | 벤슨 로버트 에이치. | 혈관 내피 성장 인자 ２ |
| US20030176674A1 (en) | 2001-04-13 | 2003-09-18 | Rosen Craig A. | Vascular endothelial growth factor 2 |
| US20030170786A1 (en) | 2001-04-13 | 2003-09-11 | Rosen Craig A. | Vascular endothelial growth factor 2 |
| JP2004536579A (ja) | 2001-04-13 | 2004-12-09 | ヒューマン ジノーム サイエンシーズ， インコーポレイテッド | 血管内皮増殖因子２ |
| AU2002313770A1 (en) | 2002-04-12 | 2003-12-02 | Human Genome Sciences, Inc. | Vascular endothelial growth factor 2 |
-
1995
- 1995-06-06 US US08/465,968 patent/US6608182B1/en not_active Expired - Fee Related
-
1996
- 1996-06-06 WO PCT/US1996/009001 patent/WO1996039515A1/en not_active Ceased
- 1996-06-06 KR KR1019970709003A patent/KR100511692B1/ko not_active Expired - Fee Related
- 1996-06-06 AU AU60467/96A patent/AU714484B2/en not_active Withdrawn - After Issue
- 1996-06-06 JP JP9501427A patent/JPH11513883A/ja not_active Withdrawn
- 1996-06-06 AT AT96918130T patent/ATE347595T1/de not_active IP Right Cessation
- 1996-06-06 DE DE69636752T patent/DE69636752T2/de not_active Revoked
- 1996-06-06 CA CA002224093A patent/CA2224093C/en not_active Expired - Fee Related
- 1996-06-06 CN CN96194405A patent/CN1186518A/zh active Pending
- 1996-06-06 EP EP96918130A patent/EP0837934B1/en not_active Revoked
- 1996-06-06 CN CNA2004100022261A patent/CN1552855A/zh active Pending
-
1999
- 1999-05-26 JP JP11147333A patent/JP2000069982A/ja not_active Withdrawn
-
2002
- 2002-04-23 US US10/127,551 patent/US7115392B2/en not_active Expired - Fee Related
-
2007
- 2007-04-13 JP JP2007106593A patent/JP2007244388A/ja active Pending
-
2008
- 2008-10-24 US US12/258,109 patent/US20100143360A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0837934B1 (en) | Human vascular endothelial growth factor 2 | |
| US7227005B1 (en) | Vascular endothelial growth factor 2 | |
| US20100041136A1 (en) | Connective Tissue Growth Factor-2 | |
| JP2006238893A (ja) | 血管内皮細胞増殖因子２ | |
| EP0873348A1 (en) | Human vascular endothelial growth factor 3 | |
| US7576189B2 (en) | Antibodies to human vascular endothelial growth factor 2 and methods of using the same | |
| US7153827B1 (en) | Vascular endothelial growth factor 2 and methods of use | |
| WO1997035976A2 (en) | Epidermal differentiation factor | |
| WO1997035976A9 (en) | Epidermal differentiation factor | |
| AU714165B2 (en) | Human criptin growth factor | |
| AU752206B2 (en) | Extracellular/epidermal growth factor like protein | |
| AU716100B2 (en) | Human vascular endothelial growth factor 3 | |
| US20020049304A1 (en) | Human CCN-like growth factor | |
| AU780633B2 (en) | Transforming growth factor alpha HII | |
| AU2005200574A1 (en) | Human Vascular Endothelial Factor 2 | |
| CA2413012A1 (en) | Human vascular endothelial growth factor 2 | |
| MXPA97009243A (en) | Human vascular endothelial growth factor | |
| US20040229787A1 (en) | Transforming growth factor alpha Hlll | |
| AU1951100A (en) | Human vascular endothelial growth factor 2 | |
| AU1541402A (en) | Human vascular endothelial growth factor 2 | |
| MXPA97009570A (en) | Growth factor 3 endothelial, vascular, hum | |
| JP2002247983A (ja) | ヒト血管ｉｂｐ様成長因子 | |
| AU2780600A (en) | Human vascular endothelial growth factor 3 | |
| CA2206640A1 (en) | Human vascular ibp-like growth factor | |
| AU2005244575A1 (en) | Human Vascular Endothelial Growth Factor 2 |